Pattern Computer® files provisional patents for 14 insilico drug discoveries targeting metastatic castration-resistant prostate cancer.

Pattern Computer® files provisional patent applications for 14 insilico drug discoveries targeting metastatic castration-resistant prostate cancer. These applications aim to strengthen Pattern's intellectual property and expand its industry-leading oncology pipeline. Filed with the USPTO, the patent applications cover potential synergistic drug combinations for the treatment.